29 reports of this reaction
2.5% of all CAMPHOR reports
#3 most reported adverse reaction
DRUG HYPERSENSITIVITY is the #3 most commonly reported adverse reaction for CAMPHOR, manufactured by Strides Consumer LLC. There are 29 FDA adverse event reports linking CAMPHOR to DRUG HYPERSENSITIVITY. This represents approximately 2.5% of all 1,159 adverse event reports for this drug.
Patients taking CAMPHOR who experience drug hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG HYPERSENSITIVITY is a less commonly reported adverse event for CAMPHOR, but still significant enough to appear in the safety profile.
In addition to drug hypersensitivity, the following adverse reactions have been reported for CAMPHOR:
The following drugs have also been linked to drug hypersensitivity in FDA adverse event reports:
DRUG HYPERSENSITIVITY has been reported as an adverse event in 29 FDA reports for CAMPHOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG HYPERSENSITIVITY accounts for approximately 2.5% of all adverse event reports for CAMPHOR, making it one of the most commonly reported side effect.
If you experience drug hypersensitivity while taking CAMPHOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.